[1] |
Eirin A, Lerman A, Lerman LO. Mitochondrial injury and dysfunction in hypertension-induced cardiac damage. Eur Heart J, 2014; 35, 3258−66. doi: 10.1093/eurheartj/ehu436 |
[2] |
Eirin A, Lerman A, Lerman LO. Mitochondria: a pathogenic paradigm in hypertensive renal disease. Hypertension, 2015; 65, 264−70. doi: 10.1161/HYPERTENSIONAHA.114.04598 |
[3] |
Nakano Y, Nakatani Y, Takami M, et al. Diverse associations between oxidative stress and thromboxane A2 in hypertensive glomerular injury. Hypertens Res, 2019; 42, 450−8. doi: 10.1038/s41440-018-0162-x |
[4] |
Whitaker RM, Stallons LJ, Kneff JE, et al. Urinary mitochondrial DNA is a biomarker of mitochondrial disruption and renal dysfunction in acute kidney injury. Kidney Int, 2015; 88, 1336−44. doi: 10.1038/ki.2015.240 |
[5] |
Lei L, Guo J, Shi X, et al. Mitochondrial DNA copy number in peripheral blood cell and hypertension risk among mining workers: a case-control study in Chinese coal miners. J Human Hyperten, 2017; 31, 585−90. doi: 10.1038/jhh.2017.30 |
[6] |
Xing JL, Chen M, Wood CG, et al. Mitochondrial DNA content: Its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst, 2008; 100, 1104−12. doi: 10.1093/jnci/djn213 |
[7] |
Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med, 2010; 29, 1037−57. |
[8] |
Clay Montier LL, Deng JJ, Bai Y. Number matters: control of mammalian mitochondrial DNA copy number. J Genet Genomics, 2009; 36, 125−31. doi: 10.1016/S1673-8527(08)60099-5 |